在状细胞病患者中,高血解综合征的临床和遗传学
Barbara Malta1,2, Mina Cintho Ozahata2, Isabel Cristina Gomes Moura3
1Fundação Hemominas, Fundação Hemominas, Belo Horizonte, Brazil.
Transfusion
|April 2, 2025
概括
在状细胞病 (SCD) 患者中,高血解综合征 (HHS) 与红细胞代谢抗体和特定的遗传变异有关. 识别这些因素可以帮助预测和预防这种严重的输血并发症.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 超血解综合征 (HHS) 是复杂免疫机制的状细胞疾病 (SCD) 的严重输血并发症.
- 关于HHS的临床和分子风险因素的研究有限,这阻碍了患者的识别.
- 这项研究调查了与HHS易感性相关的临床因素和遗传变异.
研究的目的:
- 在状细胞病 (SCD) 患者中确定与高血解综合征 (HHS) 相关的临床因素.
- 通过候选基因方法发现增加对HHS敏感性的遗传变异.
主要方法:
- 分析了REDS-III队列 (TOPMed计划) 中2793名SCD患者的全基因组测序数据.
- 临床和实验室数据被追溯收集并与HHS患者和匹配的对照进行了比较.
- 评估了与HHS相关的单核酸变异 (SNV),自身免疫力和红细胞 (RBC) 免疫.
主要成果:
- HHS发生在1.13%的患者中,主要是那些具有HbSS基因型 (69.2%) 和红血细胞附抗体 (61.5%) 的患者.
- 青少年和年轻成年人 (11-20岁) 受影响最大,疼痛危机是常见的输血指示 (41.7%).
- 他们发现了三个重要的基因变异:rs10748663 (BLNK),rs936469 (PHRF1) 和rs6503691 (STAT5B).
结论:
- HHS主要影响年轻的SCD患者,具有RBC配方抗体,通常在输血后.
- 在STAT5B和IRF7-PHRF1区域的遗传变异涉及B细胞受体信号在HHS病理生理学.
- 这些发现表明B细胞分化途径在HHS的发展中发挥了作用.
更多相关视频
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
9.7K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.3K
相关概念视频
Multiple Allele Traits
33.9K
The Concept of Multiple Allelism
33.9K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Disorders of Hemostasis
674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Erythropoiesis
4.0K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.0K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
